Stebabiotech.com

Stebabiotech.com has Server used 46.226.110.201 IP Address with Hostname in Luxembourg. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2000-11-29 (20 years, 240 days) and hosted in Luxembourg, server ping response time 174 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Stebabiotech keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Steba biotech
2 Steba biotech hq
3 Steba biotech sa
4 Steba biotech stock
5 Steba biotech address

Hosting Provider

Website: Stebabiotech.com
Hostname: xvm-110-201.dc2.ghst.net
Country:
Latitude: 49.75
Longitude: 6.166699886322
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Aiwasun.com (1 seconds ago)

   » Trsmiles.com (18 seconds ago)

   » 0855tv.org (1 seconds ago)

   » Madrideasy.com (3 seconds ago)

   » Coachingwithclark.com (3 seconds ago)

   » Butterballtenderloin.com (9 seconds ago)

   » Townofbecket.org (4 seconds ago)

   » Touchstonecrystal.com (2 seconds ago)

   » Archivesalberta.org (1 seconds ago)

   » Flautism.com (29 seconds ago)

Results For Websites Listing

Found 44 Websites with content related to this domain, It is result after search with search engine

Steba Biotech Company Profile

Craft.co   DA: 8 PA: 14 MOZ Rank: 22

  • Steba Biotech is a company that provides therapeutic solutions for the treatment of cancers
  • It is engaged in research focusing on prostate cancer, oesophagus cancer, urothelial cell carcinoma, kidney cancer, triple-negative breast cancer, and pancreatic cancer.

Steba Biotech S.A LinkedIn

Linkedin.com   DA: 16 PA: 25 MOZ Rank: 42

  • Steba Biotech is focused on the development and launch of ImPACT - Immune Photo Activated Cancer Therapy, a targeted treatment for selective tumor ablation
  • The company is headquartered in

Steba Biotech's TOOKAD® Vascular Photodynamic Therapy

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 70

Steba Biotech is focused on the development of TOOKAD® (padeliporfin di-potassium), an innovative and minimally invasive photodynamic therapy evaluated in late-stage clinical trials to

FDA Committee Votes Against Approval Of Tookad For

Healio.com   DA: 14 PA: 50 MOZ Rank: 67

Padeliporfin di-potassium (Steba Biotech), also called Tookad Vascular-Targeted Photodynamic (VTP) therapy, is a partial gland ablation treatment …

Too Bad For Tookad: FDA Adcom Votes Against Steba’s

Bioworld.com   DA: 16 PA: 50 MOZ Rank: 70

Citing what it called poor study design and execution coupled with a lack of follow-up data, the FDA’s Oncologic Drugs Advisory Committee voted 13-2 against recommending approval of Steba Biotech SA’s NDA for Tookad (padeliporfin dipotassium) for injection in men with localized early stage prostate cancer.

PowerPoint Presentation

Fda.gov   DA: 11 PA: 22 MOZ Rank: 38

  • Steba Biotech Inderbir Gill, MD University of Southern California
  • Additional Experts Statistics co-IO Marc Buyse, ScD Founder International Drug Development Institute CluePoints

FDA Grants Fast Track Designation To Novel Treatment For UTUC

Urologytimes.com   DA: 20 PA: 50 MOZ Rank: 76

  • The FDA has granted a Fast Track designation to padeliporfin Immune Photo Activated Cancer Therapy (ImPACT) for the treatment of adult patients with low-grade and unifocal high-grade upper tract urothelial cancer (UTUC), according to Steba biotech, the developer of the investigational treatment
  • 1 The padeliporfin ImPACT platform involves the intravenous delivery and activation of the

ENdoluminal LIGHT ActivatED Treatment Of Upper Tract

Clinicaltrials.gov   DA: 18 PA: 21 MOZ Rank: 46

  • ClinicalTrials.gov Identifier: NCT04620239 Other Study ID Numbers: CLIN2001 UCM301 : First Posted: November 6, 2020 Key Record Dates: Last Update Posted: March 29, 2021 Last Verified: March 2021 Individual Participant Data …

Steba Biotech SA, Luxembourg

Firmenwissen.com   DA: 20 PA: 50 MOZ Rank: 78

  • Steba Biotech SA has its registered office in Luxembourg, Luxembourg
  • Its current status is listed as active
  • The company is registered at the Registre de commerce et des sociétés at the local court of Luxembourg with the legal form of Société Anonyme (number B 122.394).

Steba Biotech Ltd. LinkedIn

Linkedin.com   DA: 16 PA: 27 MOZ Rank: 52

  • Photodynamic therapy for prostate cancer Photodynamic Therapy (PDT) is a sophisticated and powerful technique that can be used for cancer treatment

Phase 3 Study Launches Of Padeliporfin ImPACT For UTUC

Urologytimes.com   DA: 20 PA: 50 MOZ Rank: 80

  • The first patient has been diagnosed in the pivotal phase 3 ENLIGHTED trial exploring padeliporfin Immune Photo Activated Cancer Therapy (ImPACT) for the treatment of patients with low-grade upper tract urothelial cancer (UTUC), according to Steba Biotech, the developer of the investigational treatment
  • 1 The padeliporfin ImPACT platform involves the intravenous delivery and …

Steba Biotech Receives FDA Orphan Drug Designation For

Biospace.com   DA: 16 PA: 50 MOZ Rank: 77

  • Steba biotech is a Luxembourg based biotech organization founded in 1996 with operations in the EU, Israel and the US
  • Steba biotech is focused on the development of a novel oncology platform to treat a range of solid tumors with padeliporfin ImPACT (Immune Photo Activated Cancer Therapy).

Steba Biotech SA Company Profile Genève, GENÈVE

Dnb.com   DA: 11 PA: 50 MOZ Rank: 73

  • Steba Biotech SA is located in Genève, GENÈVE, Switzerland and is part of the Consulting Services Industry
  • Steba Biotech SA has 1 employees at this location and generates $83,572 in sales (USD)
  • D&B Hoovers provides sales leads and sales intelligence data on over 120 million companies like Steba Biotech SA around the world, including

Randomized Trial Of Partial Gland Ablation With Vascular

Pubmed.ncbi.nlm.nih.gov   DA: 23 PA: 10 MOZ Rank: 46

  • 6 Department of Plants and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel
  • 7 Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • Electronic address: [email protected]

STEBA BIOTECH LIMITED Israel Company Reports

Israelbizreg.com   DA: 20 PA: 22 MOZ Rank: 56

  • Located in Jerusalem, Israel, STEBA BIOTECH LIMITED is a business that IsraelBizReg can provide a detailed report on
  • Within 12 to 36 hours after you place an order, your reports will be ready for you
  • Legal & bankruptcy reports can sometimes take a bit longer depending on the amount of results.

Top Steba Biotech Competitors And Alternatives Craft.co

Craft.co   DA: 8 PA: 26 MOZ Rank: 49

  • Steba Biotech's main competitors include Rad Source Technologies, Northwestern Medicine Proton Center, Accuray and Amethyst Radiotherapy
  • Compare Steba Biotech to its competitors by revenue, employee growth and other metrics at Craft.

FDA Grants Fast Track Designation To Padeliporfin ImPACT

Biospace.com   DA: 16 PA: 50 MOZ Rank: 82

  • About Steba biotech Steba biotech is a Luxembourg based biotech organization founded in 2002 with operations in the EU, Israel and the US
  • Steba biotech is focused on the development of a novel oncology platform to treat a range of solid tumors with padeliporfin ImPACT ( Im mune P hoto A ctivated C ancer T herapy).

FDA Grants Fast Track Designation To Padeliporfin ImPACT

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 85

Steba biotech's strong relationships with The Weizmann Institute in Israel and Memorial Sloan Kettering Cancer Center in the US have produced …

TOOKAD Soluble Approved For Prostate Cancer Therapy In Mexico

Medicalxpress.com   DA: 17 PA: 50 MOZ Rank: 85

A therapy invented at the Weizmann Institute of Science and clinically developed in collaboration with Steba Biotech (Luxembourg) has been approved by Cofepris, Mexico's health authority, for …

February 26, 2020: Meeting Of The Oncologic Drugs Advisory

Fda.gov   DA: 11 PA: 50 MOZ Rank: 80

  • During the morning session, the committee will discuss new drug application 212578 for padeliporfin di-potassium powder for solution for injection, submitted by STEBA Biotech, S.A.

Steba Biotech Treats First Patient In Pivotal ENLIGHTED

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 87

LUXEMBOURG, April 20, 2021 (GLOBE NEWSWIRE) -- Steba Biotech, the pioneering Immune Photo Activate Cancer Treatment (ImPACT) specialist, today announces the treatment of …

TOOKAD®, Invented At The Weizmann Institute Of Science

Wis-wander.weizmann.ac.il   DA: 25 PA: 50 MOZ Rank: 96

Steba Biotech, a privately-owned company, in collaboration with scientists at the Weizmann Institute of Science, has conduct extensive research and development on TOOKAD®, and has received marketing authorization to make TOOKAD® available in 31 European countries.Following this regulatory approval, the first patients are currently being treated in top Israeli, German, English and …

FDA Grants Fast Track Designation To Padeliporfin ImPACT

Apnews.com   DA: 10 PA: 50 MOZ Rank: 82

  • Steba biotech is a Luxembourg based biotech organization founded in 2002 with operations in the EU, Israel and the US
  • Steba biotech is focused on the development of a novel oncology platform to treat a range of solid tumors with padeliporfin ImPACT (Immune Photo Activated Cancer Therapy)
  • Under the guidance of a new leadership team, Steba

EMA Approves Steba’s Prostate Cancer Drug Weizmann USA

Weizmann-usa.org   DA: 20 PA: 50 MOZ Rank: 93

  • Steba Biotech was founded by Raphael Harari and his son, Fabrice Harari, Jews currently residing in Switzerland who founded European drug company Negma Laboratories and sold it for $250 million
  • Among other reasons, Negma Laboratories was sold to finance Steba Biotech, which currently has dozens of employees, including 30 in Rehovot.

FDA Grants Fast Track Designation To Padeliporfin ImPACT

Wfmz.com   DA: 12 PA: 50 MOZ Rank: 86

  • 15, 2021 /PRNewswire/ -- Steba biotech, pioneering developer of the IMmune Photo Activate Cancer Treatment (ImPACT), announced today …

Steba Biotech Treats First Patient In Pivotal ENLIGHTED

In.finance.yahoo.com   DA: 20 PA: 50 MOZ Rank: 95

Contacts Chief Commercial OfficerInvestor Relations LifeSci AdvisorsSteba biotech S.AGuillaume van RenterghemChris Grimes-Crompton [email protected] [email protected]stebabiotech

Steba Biotech Treats First Patient In Pivotal ENLIGHTED

Tmcnet.com   DA: 14 PA: 50 MOZ Rank: 90

  • Steba Biotech is a Luxembourg based biotech company founded in 1996
  • It is focused on developing a novel potential cancer therapy, Padeliporfin ImPACT, considered a potential new chemical entity by FDA/EMA
  • Padeliporfin ImPACT offers surgery-like efficacy combined with organ preservation
  • The activation of Padeliporfin in the tumor has been

Steba Biotech Archives

Massdevice.com   DA: 18 PA: 19 MOZ Rank: 64

  • Study: Laser-activated deep-sea drug kills prostate cancer
  • December 20, 2016 By Sarah Faulkner
  • Researchers from the Weizmann Institute of …

Steba Offers Prostate Cancer Patients A Better Approach

Weizmann-usa.org   DA: 20 PA: 50 MOZ Rank: 98

  • It takes a village to bring a new treatment to market – and in the case of the prostate cancer therapy developed by Profs
  • Avigdor Scherz and Yoram Salomon, that village includes Steba Biotech, which said ""We looked at the technology for ten minutes and said, ‘We'll take it'."" Globes interviews the father and son behind the Israel-based pharmaceutical house.

Steba Biotech Treats First Patient In Pivotal ENLIGHTED

Ca.finance.yahoo.com   DA: 20 PA: 50 MOZ Rank: 99

  • About Steba Biotech Steba Biotech is a Luxembourg based biotech company founded in 1996
  • It is focused on developing a novel potential cancer therapy, Padeliporfin ImPACT, considered a potential new chemical entity by FDA/EMA
  • Padeliporfin ImPACT offers surgery-like efficacy combined with organ preservation.

Steba Biotech Treats First Patient In Pivotal ENLIGHTED

Nz.finance.yahoo.com   DA: 20 PA: 50 MOZ Rank: 100

  • About Steba Biotech Steba Biotech is a Luxembourg based biotech company founded in 1996
  • It is focused on developing a novel potential cancer therapy, Padeliporfin ImPACT, considered a potential new chemical entity by FDA/EMA
  • Padeliporfin ImPACT offers surgery-like efficacy combined with organ preservation.

Recently Analyzed Sites

Aiwasun.com (2 seconds ago)

Trsmiles.com (19 seconds ago)

0855tv.org (2 seconds ago)

Compasshousemedical.com (0 seconds ago)

Coachingwithclark.com (4 seconds ago)

Butterballtenderloin.com (10 seconds ago)

Townofbecket.org (5 seconds ago)

Touchstonecrystal.com (3 seconds ago)

Archivesalberta.org (2 seconds ago)

Baoduongmaytinh.com (1 seconds ago)

Kathleenchiolo.com (4 seconds ago)

Lakevillage.com (17 seconds ago)

Keypartsonline.com (8 seconds ago)

Hargavimax.org (16 seconds ago)

Nutritionaltree.com (15 seconds ago)

Yourbachparty.com (2 seconds ago)

Eramosa.com (13 seconds ago)

Egakkiya.com (1 seconds ago)